Gladwin MT - Search Results

1

Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality.

Kato GJ, Martyr S, Blackwelder WC, Nichols JS, Coles WA, Hunter LA, Brennan ML, Hazen SL, Gladwin MT. Kato GJ, et al. Among authors: gladwin mt. Br J Haematol. 2005 Sep;130(6):943-53. doi: 10.1111/j.1365-2141.2005.05701.x. Br J Haematol. 2005. PMID: 16156864 Free PMC article.

2

Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity.

Gladwin MT, Schechter AN, Shelhamer JH, Pannell LK, Conway DA, Hrinczenko BW, Nichols JS, Pease-Fye ME, Noguchi CT, Rodgers GP, Ognibene FP. Gladwin MT, et al. J Clin Invest. 1999 Oct;104(7):937-45. doi: 10.1172/JCI7637. J Clin Invest. 1999. PMID: 10510334 Free PMC article.

3

Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation.

Gladwin MT, Ognibene FP, Pannell LK, Nichols JS, Pease-Fye ME, Shelhamer JH, Schechter AN. Gladwin MT, et al. Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):9943-8. doi: 10.1073/pnas.180155397. Proc Natl Acad Sci U S A. 2000. PMID: 10954746 Free PMC article.

4

Effect of nitric oxide and nitric oxide donors on red blood cell oxygen transport.

Hrinczenko BW, Alayash AI, Wink DA, Gladwin MT, Rodgers GP, Schechter AN. Hrinczenko BW, et al. Among authors: gladwin mt. Br J Haematol. 2000 Aug;110(2):412-9. doi: 10.1046/j.1365-2141.2000.02203.x. Br J Haematol. 2000. PMID: 10971400 Free article.

5

Nitric oxide therapy in sickle cell disease.

Gladwin MT, Schechter AN. Gladwin MT, et al. Semin Hematol. 2001 Oct;38(4):333-42. doi: 10.1016/s0037-1963(01)90027-7. Semin Hematol. 2001. PMID: 11605168 Review.

6

Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease.

Gladwin MT, Shelhamer JH, Ognibene FP, Pease-Fye ME, Nichols JS, Link B, Patel DB, Jankowski MA, Pannell LK, Schechter AN, Rodgers GP. Gladwin MT, et al. Br J Haematol. 2002 Feb;116(2):436-44. doi: 10.1046/j.1365-2141.2002.03274.x. Br J Haematol. 2002. PMID: 11841449 Free article.

7

Renal pathology in hemizygous sickle cell mice.

Diwan BA, Gladwin MT, Noguchi CT, Ward JM, Fitzhugh AL, Buzard GS. Diwan BA, et al. Among authors: gladwin mt. Toxicol Pathol. 2002 Mar-Apr;30(2):254-62. doi: 10.1080/019262302753559597. Toxicol Pathol. 2002. PMID: 11950169

8

Effects of iron nitrosylation on sickle cell hemoglobin solubility.

Xu X, Lockamy VL, Chen K, Huang Z, Shields H, King SB, Ballas SK, Nichols JS, Gladwin MT, Noguchi CT, Schechter AN, Kim-Shapiro DB. Xu X, et al. Among authors: gladwin mt. J Biol Chem. 2002 Sep 27;277(39):36787-92. doi: 10.1074/jbc.M205350200. Epub 2002 Jul 22. J Biol Chem. 2002. PMID: 12138112 Free article.

9

Divergent nitric oxide bioavailability in men and women with sickle cell disease.

Gladwin MT, Schechter AN, Ognibene FP, Coles WA, Reiter CD, Schenke WH, Csako G, Waclawiw MA, Panza JA, Cannon RO 3rd. Gladwin MT, et al. Circulation. 2003 Jan 21;107(2):271-8. doi: 10.1161/01.cir.0000044943.12533.a8. Circulation. 2003. PMID: 12538427 Clinical Trial.

10

Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation.

Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X, Huang KT, Shields H, Kim-Shapiro DB, Schechter AN, Cannon RO 3rd, Gladwin MT. Cosby K, et al. Among authors: gladwin mt. Nat Med. 2003 Dec;9(12):1498-505. doi: 10.1038/nm954. Epub 2003 Nov 2. Nat Med. 2003. PMID: 14595407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

509 results

Search Page

Filters